Shanghai Zhongshan Hospital: Liver Neoplasms trials
The registry lists 13 Liver Neoplasms studies with Shanghai Zhongshan Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 5No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic CholangiocarcinomaNot yet recruitingNCT07685535Phase 2
- HAIC-TACE Plus Apatinib and Camrelizumab for Liver CancerNot yet recruitingNCT07587034Phase 1/2
- Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaNot yet recruitingNCT07243951Phase 2
- A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular CancerNot yet recruitingNCT06935175Phase 2
- Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical StudyRecruitingNCT06794073Not applicable
- A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver CancerNot yet recruitingNCT06356623
- PDO/PDO-TIL/PDOTS for Drug ScreenRecruitingNCT05913141
- Clinical Study of mRNA Vaccine in Patients With Liver Cancer After OperationNot yet recruitingNCT05761717Not applicable
- Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC PatientsCompletedNCT07321613
- External Validation of the Apfel Risk Score and Koivuranta Score to Predict Postoperative Nausea and Vomiting in Patients With Liver CancerStatus unknownNCT05014737
- Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver ResectionStatus unknownNCT03352349Phase 2
- Standardization of Multi-modal Tumor Ablation Therapy SystemStatus unknownNCT03223142Not applicable
- Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver CancerStatus unknownNCT02644603Not applicable